19 Jan 2022 Jyseleca®▼ (Filgotinib) licensed for the treatment of adult patients with moderately to severely active ulcerative colitis in Great Britain Member news
14 Jan 2022 Mithra announces positive top-line results from Donesta® Phase 3 studies in menopausal women Member news
12 Jan 2022 Biotalys and Olon enter into long-term partnership for the production of protein-based biocontrols Member news
12 Jan 2022 Biohaven enters exclusive license and research collaboration agreement with KU Leuven to advance first-in-class TRPM3 antagonists for the treatment of pain Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
